Notably, in CLL, CD44v and VLA-4 constitute a cell surface docking complex for matrix metalloproteinase 9 (MMP-9) (in the pro and active form) (30). This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.